Evidence map›Paper›PMID 35414066›Full record

ArticleScientific reports2022

Laminin matrix regulates beta-cell FGFR5 expression to enhance glucose-stimulated metabolism.

Vidhant Pal, Yufeng Wang, Romario Regeenes, Dawn M Kilkenny, Jonathan V Rocheleau

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Targeting Apollo-NADPACS sensors · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vidhant PalInstitute of Biomedical Engineering, University of Toronto, Toronto, Canada.
Yufeng WangInstitute of Biomedical Engineering, University of Toronto, Toronto, Canada.
Romario RegeenesInstitute of Biomedical Engineering, University of Toronto, Toronto, Canada.
Dawn M KilkennyInstitute of Biomedical Engineering, University of Toronto, Toronto, Canada. dawn.kilkenny@utoronto.ca.
Jonathan V RocheleauInstitute of Biomedical Engineering, University of Toronto, Toronto, Canada. Jon.Rocheleau@utoronto.ca.
Toronto General Hospital · CAUniversity of Toronto · CAUniversity Health Network · CA

Funding

CIHR 162330
6 · The paper itself

Abstract

We previously showed that pancreatic beta-cells plated on laminin matrix express reduced levels of FGFR1, a receptor linked to beta-cell metabolism and differentiation. Due to recent evidence that adult beta-cells also express FGFR5, a co-receptor for FGFR1, we now aim to determine the effect of laminin on FGFR5 expression and consequent effects on beta-cell metabolism. Using a genetically encoded sensor for NADPH/NADP

Indexed as

Insulin-Secreting CellsLamininAnimalsGlucokinaseGlucoseInsulinMiceNADPGlucokinaseGlucoseInsulinLamininNADP

Identifiers

PMID35414066
PMCPMC9005713
OpenAlexW4223463116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.